AMRX Amneal Pharmaceuticals Inc - Class A

  1. Stocks
  2. Healthcare
  3. NASDAQ: AMRX

Price (delayed)

$17.27

Market cap

$5.52B

P/E Ratio

34.54

Dividend/share

N/A

EPS

$0.5

Enterprise value

$8.17B

?
Relative Growth: Rel. Growth: 79
Relative Strength: Rel. Strength: 86
Relative Valuation: Rel. Valuation: 79
Relative Profitability: Rel. Profitability: 56
Highlights
Amneal Pharmaceuticals Inc - Class A's equity has surged by 173% QoQ and by 129% YoY
The P/E is 78% below the last 4 quarters average of 155.4
AMRX's quick ratio has soared by 64% YoY but it is down by 10% from the previous quarter
AMRX's debt is up by 8% year-on-year and by 3.5% since the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.amneal.com

Key stats

What are the main financial stats of AMRX

AMRX stock price

How has the Amneal Pharmaceuticals Inc - Class A stock price performed over time
Intraday
-2.21%
1 week
-4.43%
1 month
0.52%
1 year
83.72%
YTD
37.06%
QTD
-0.23%

Financial performance

How have Amneal Pharmaceuticals Inc - Class A's revenue and profit performed over time
Revenue
$3.12B
Gross profit
$1.23B
Operating income
$453.92M
Net income
$157.36M
Gross margin
39.3%
Net margin
5%
The company's net income rose by 29% QoQ
AMRX's net margin is up by 25% since the previous quarter
The company's operating income rose by 21% YoY and by 4.2% QoQ
The company's gross profit rose by 14% YoY and by 4.1% QoQ

Price vs fundamentals

How does AMRX's price correlate with its fundamentals

Growth

What is Amneal Pharmaceuticals Inc - Class A's growth rate over time

Valuation

What is Amneal Pharmaceuticals Inc - Class A stock price valuation
AMRX P/E details
P/E
34.54
P/B
166.83
P/S
1.77
EV/EBIT
22.04
EV/EBITDA
14.46
EV/Sales
2.62
The P/E is 78% below the last 4 quarters average of 155.4
AMRX's EPS is up by 28% since the previous quarter
Amneal Pharmaceuticals Inc - Class A's equity has surged by 173% QoQ and by 129% YoY
The price to sales (P/S) is 153% higher than the 5-year quarterly average of 0.7 and 26% higher than the last 4 quarters average of 1.4
AMRX's revenue is up by 9% year-on-year and by 2.4% since the previous quarter

Efficiency

How efficient is Amneal Pharmaceuticals Inc - Class A business performance
The company's return on assets rose by 26% QoQ
AMRX's ROS is up by 17% year-on-year
AMRX's ROIC is up by 10% YoY

Dividends

What is AMRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMRX.

Financial health

How did Amneal Pharmaceuticals Inc - Class A financials performed over time
AMRX's quick ratio has soared by 64% YoY but it is down by 10% from the previous quarter
The company's current ratio has surged by 54% YoY but it fell by 11% QoQ
Amneal Pharmaceuticals Inc - Class A's equity has surged by 173% QoQ and by 129% YoY
AMRX's debt is up by 8% year-on-year and by 3.5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.